(Q37801865)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963522%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963522%20AND%20SRC:MED&resulttype=core&format=json

lymphoproliferative disorders

15 February 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963522%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Leo Gordon

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963522%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Rupali Roy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963522%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Danielle Sterrenberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963522%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Michelle Z Moll

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963522%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Amy Chadburn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963522%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

1 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963522%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

published in

Current Oncology Reports

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963522%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963522%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963522%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

383-394

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963522%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11912-010-0132-1

15 February 2020

exact match

0 references

cites work

Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Post-transplant lymphoproliferative disorder: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Treatment of PTLD with rituximab or chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Identifying the patient at risk for post-transplant lymphoproliferative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

How I treat EBV lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Virostatic therapy for advanced lymphoproliferation associated with the Epstein-Barr virus in an HIV-infected patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Treatment of Epstein-Barr virus-induced posttransplantation lymphoproliferative disorder with foscarnet alone in an adult after simultaneous heart and renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Posttransplant lymphoproliferative disorder: significance of central nervous system involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Efficacy and tolerability of high-dose methotrexate in central nervous system positive or relapsed lymphoproliferative disease following liver transplant in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Adoptive cellular immunotherapy for viral diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Lymphomas occurring late after solid-organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0132-1

Post-transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities

21 January 2018

1 reference

12 December 2020

Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: A report of 16 cases observed in a single center.

1 reference

12 December 2020

Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders

1 reference

12 December 2020

Lymphomas after solid organ transplantation: a collaborative transplant study report

1 reference

12 December 2020

Malignant lymphomas in transplantation patients

1 reference

12 December 2020

Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants

1 reference

12 December 2020

Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders.

1 reference

12 December 2020

CHOP-21 for the treatment of post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation

1 reference

12 December 2020

Central nervous system lymphomas in organ allograft recipients

1 reference

12 December 2020

Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial

1 reference

12 December 2020

CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation

1 reference

12 December 2020

Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome.

1 reference

12 December 2020

Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcome

1 reference

12 December 2020

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

1 reference

12 December 2020

Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?

1 reference

12 December 2020

Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium

1 reference

12 December 2020

Molecular pathology of posttransplantation lymphoproliferative disorders

1 reference

12 December 2020

Histogenetic phenotypes of B cells in posttransplant lymphoproliferative disorders by immunohistochemical analysis correlate with transplant type: solid organ vs hematopoietic stem cell transplantation

1 reference

12 December 2020

Aggressive treatment for postcardiac transplant lymphoproliferation

1 reference

12 December 2020

Clinical and pathological prognostic markers for survival in adult patients with post-transplant lymphoproliferative disorders in solid transplant

1 reference

12 December 2020

10.1007/S11912-010-0132-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963522%20AND%20SRC:MED&resulttype=core&format=json

release_arzvp3okxfcwnlp6uft3xpmbcy

15 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/arzvp3okxfcwnlp6uft3xpmbcy

24 November 2022

mapped directly with Wikidata item

1 reference